Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial
Russell L. Rothman, Thomas G. Stewart, Ahmad Mourad, David R. Boulware, Matthew W. McCarthy, Florence Thicklin, Idania T. Garcia del Sol, Jose Luis Garcia, View ORCID ProfileCarolyn T. Bramante, Nirav S. Shah, Upinder Singh, John C. Williamson, Paulina A. Rebolledo, View ORCID ProfilePrasanna Jagannathan, Tiffany Schwasinger-Schmidt, Adit A. Ginde, Mario Castro, Dushyantha Jayaweera, Mark Sulkowski, Nina Gentile, Kathleen McTigue, G. Michael Felker, Allison DeLong, Rhonda Wilder, Sean Collins, Sarah E. Dunsmore, Stacey J. Adam, George J. Hanna, Elizabeth Shenkman, Adrian F. Hernandez, Susanna Naggie, Christopher J. Lindsell, Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators
doi: https://doi.org/10.1101/2024.05.16.24307115
Russell L. Rothman
1Vanderbilt University Medical Center, Nashville, TN
MD, MPPThomas G. Stewart
2School of Data Science, University of Virginia, Charlottesville, VA
PhDAhmad Mourad
3Department of Medicine, Duke University School of Medicine, Durham, NC
4Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC
MDDavid R. Boulware
5Departmnet of Medicine, University of Minnesota Medical School, Minneapolis, MN
MD, MPHMatthew W. McCarthy
6Weill Cornell Medicine, New York, NY;
MDFlorence Thicklin
7Stakeholder Advisory Committee, Pittsburgh, PA
Idania T. Garcia del Sol
8L&A Morales Healthcare, Inc., Hialeah, FL
MDJose Luis Garcia
9The Angel Medical Research Corporation, Miami Lakes, FL
MDCarolyn T. Bramante
5Departmnet of Medicine, University of Minnesota Medical School, Minneapolis, MN
MD, MPHNirav S. Shah
10Endeavor Health, Evanston, IL
MD, MPHUpinder Singh
11Stanford University School of Medicine, Stanford, CA
MDJohn C. Williamson
12Wake Forest University School of Medicine, Department of Internal Medicine, Section on Infectious Diseases, Winston-Salem, NC
PharmDPaulina A. Rebolledo
13Department of Medicine and Global Health, Division of Infectious Diseases, Emory University School of Medicine and Rollins School of Public Health, Atlanta, GA
MD, MScPrasanna Jagannathan
11Stanford University School of Medicine, Stanford, CA
MDTiffany Schwasinger-Schmidt
14University of Kansas School of Medicine-Wichita, Center for Clinical Research, Wichita, KS
MD, PhDAdit A. Ginde
15University of Colorado School of Medicine, Aurora, CO
MD, MPHMario Castro
16Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, KS
MD, MPHDushyantha Jayaweera
17Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL
MDMark Sulkowski
18Division of Infectious Diseases, Johns Hopkins University, Baltimore, MD
MDNina Gentile
19Department of Emergency Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
MDKathleen McTigue
20Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA
MDG. Michael Felker
4Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC
5Departmnet of Medicine, University of Minnesota Medical School, Minneapolis, MN
MD, MHSAllison DeLong
5Departmnet of Medicine, University of Minnesota Medical School, Minneapolis, MN
BSRhonda Wilder
5Departmnet of Medicine, University of Minnesota Medical School, Minneapolis, MN
MSSean Collins
1Vanderbilt University Medical Center, Nashville, TN
21Veterans Affairs Tennessee Valley Healthcare System, Geriatric Research, Education and Clinical Center (GRECC), Nashville, TN
MD, MSciSarah E. Dunsmore
22National Center for Advancing Translational Sciences, Bethesda, MD
PhDStacey J. Adam
23Foundation for the National Institutes of Health, Bethesda, MD
PhDGeorge J. Hanna
24Biomedical Advanced Research and Development Authority, Washington, DC
MDElizabeth Shenkman
25Department of Health Outcomes & Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL
PhDAdrian F. Hernandez
4Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC
5Departmnet of Medicine, University of Minnesota Medical School, Minneapolis, MN
MD, MHSSusanna Naggie
4Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC
5Departmnet of Medicine, University of Minnesota Medical School, Minneapolis, MN
MD, MHSChristopher J. Lindsell
5Departmnet of Medicine, University of Minnesota Medical School, Minneapolis, MN
PhDData Availability
ACTIV-6 is a platform trial using shared placebos. On completion of the platform trial, when there is no risk of unblinding across study arms, the data will be made publicly available by depositing it in an approved data repository such as NHLBI BioData Catalyst.
Posted May 18, 2024.
Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial
Russell L. Rothman, Thomas G. Stewart, Ahmad Mourad, David R. Boulware, Matthew W. McCarthy, Florence Thicklin, Idania T. Garcia del Sol, Jose Luis Garcia, Carolyn T. Bramante, Nirav S. Shah, Upinder Singh, John C. Williamson, Paulina A. Rebolledo, Prasanna Jagannathan, Tiffany Schwasinger-Schmidt, Adit A. Ginde, Mario Castro, Dushyantha Jayaweera, Mark Sulkowski, Nina Gentile, Kathleen McTigue, G. Michael Felker, Allison DeLong, Rhonda Wilder, Sean Collins, Sarah E. Dunsmore, Stacey J. Adam, George J. Hanna, Elizabeth Shenkman, Adrian F. Hernandez, Susanna Naggie, Christopher J. Lindsell, Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators
medRxiv 2024.05.16.24307115; doi: https://doi.org/10.1101/2024.05.16.24307115
Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial
Russell L. Rothman, Thomas G. Stewart, Ahmad Mourad, David R. Boulware, Matthew W. McCarthy, Florence Thicklin, Idania T. Garcia del Sol, Jose Luis Garcia, Carolyn T. Bramante, Nirav S. Shah, Upinder Singh, John C. Williamson, Paulina A. Rebolledo, Prasanna Jagannathan, Tiffany Schwasinger-Schmidt, Adit A. Ginde, Mario Castro, Dushyantha Jayaweera, Mark Sulkowski, Nina Gentile, Kathleen McTigue, G. Michael Felker, Allison DeLong, Rhonda Wilder, Sean Collins, Sarah E. Dunsmore, Stacey J. Adam, George J. Hanna, Elizabeth Shenkman, Adrian F. Hernandez, Susanna Naggie, Christopher J. Lindsell, Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators
medRxiv 2024.05.16.24307115; doi: https://doi.org/10.1101/2024.05.16.24307115
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)